Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

FDA gives salvage therapy testing a push forward.

E Bass

    AIDS Treatment News
    |September 26, 2001
    PubMed
    Summary
    This summary is machine-generated.

    Pharmaceutical companies often test drugs in less ill patients. A recent FDA meeting highlighted the need for trials in advanced patients and long-term safety monitoring for all.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Experimental Validation of a Kinetic Ballooning Mode in High-Performance High-Bootstrap Current Fraction Fusion Plasmas.

    Physical review letters·2023
    Same author

    In for the long haul: debate paves way for long-term trials.

    Research initiative, treatment action : RITA·2001
    Same author

    Variations in complication rates and opportunities for improvement in quality of care for patients having abdominal aortic surgery.

    Langenbeck's archives of surgery·2001
    Same author

    Toxicity of chlorypyrifos to Rana pipiens embryos.

    Bulletin of environmental contamination and toxicology·2001
    Same author

    [Limb-threatening ischemia--arterial reconstruction in primary amputation?].

    Harefuah·2000
    Same author

    Is outpatient laparoscopic cholecystectomy safe and cost-effective? A model to study transition of care.

    Anesthesiology·1999
    Same journal

    New kind of antiretroviral, KP-1461; clinical trial recruiting. Interview with Stephen Becker, M.D.

    AIDS treatment news·2008
    Same journal

    Flu shot reminder.

    AIDS treatment news·2008
    Same journal

    AIDS search engine wanted: what to do now?

    AIDS treatment news·2007
    Same journal

    Is cure possible for HIV?

    AIDS treatment news·2007
    Same journal

    Financial accounts that can reproduce, inherit, and evolve.

    AIDS treatment news·2007
    Same journal

    Selling digital art in bulk through prepaid URLs.

    AIDS treatment news·2007
    See all related articles

    Area of Science:

    • Clinical trials
    • Drug development
    • Patient safety

    Background:

    • Pharmaceutical companies may prioritize trials in less seriously ill patients to ensure favorable drug efficacy results.
    • This practice can lead to underrepresentation of advanced-stage patients in clinical studies.

    Discussion:

    • A recent Food and Drug Administration (FDA) meeting addressed critical issues in drug development and patient safety.
    • The discussion emphasized the necessity of including patients with advanced disease stages in clinical trials.
    • Long-term safety follow-up for all trial participants was also deemed crucial.

    Key Insights:

    • Trials should include patients with advanced disease to better understand drug performance in real-world, severe cases.
    • Comprehensive, long-term safety monitoring is essential for all patients, regardless of disease severity.

    Related Experiment Videos

  • Methods for conducting these necessary trials and monitoring protocols require further development and standardization.

    • Outlook:

    • Future clinical trial designs should incorporate more advanced patient populations.
    • Enhanced long-term safety surveillance strategies will improve post-market drug safety.
    • Regulatory bodies and pharmaceutical companies must collaborate to implement these essential changes in drug testing and monitoring.